SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Revance Therapeutics, Inc. – ‘10-K’ for 12/31/22 – ‘EX-101.SCH’

On:  Tuesday, 2/28/23, at 4:22pm ET   ·   For:  12/31/22   ·   Accession #:  1479290-23-28   ·   File #:  1-36297

Previous ‘10-K’:  ‘10-K’ on 2/28/22 for 12/31/21   ·   Next & Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   35 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/28/23  Revance Therapeutics, Inc.        10-K       12/31/22  109:14M

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   3.28M 
 2: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     47K 
 3: EX-10.12    Material Contract                                   HTML     66K 
 4: EX-10.31    Material Contract                                   HTML     31K 
 5: EX-10.46    Material Contract                                   HTML     41K 
 6: EX-23.1     Consent of Expert or Counsel                        HTML     28K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     30K 
10: EX-32.2     Certification -- §906 - SOA'02                      HTML     30K 
16: R1          Cover                                               HTML     92K 
17: R2          Audit Information                                   HTML     33K 
18: R3          Consolidated Balance Sheets                         HTML    150K 
19: R4          Consolidated Balance Sheets (Parenthetical)         HTML     46K 
20: R5          Consolidated Statements of Operations and           HTML    121K 
                Comprehensive Loss                                               
21: R6          Consolidated Statements of Stockholders' Equity     HTML    163K 
22: R7          Consolidated Statements of Cash Flows               HTML    161K 
23: R8          The Company                                         HTML     36K 
24: R9          Summary of Significant Accounting Policies          HTML     88K 
25: R10         Revenue                                             HTML    112K 
26: R11         Business Combination                                HTML     65K 
27: R12         Cash Equivalents and Short-Term Investments         HTML     63K 
28: R13         Goodwill and Intangible Assets, net                 HTML     74K 
29: R14         Inventories                                         HTML     37K 
30: R15         Balance Sheet Components                            HTML     53K 
31: R16         Leases                                              HTML     90K 
32: R17         Debt                                                HTML     63K 
33: R18         Stock-based Compensation                            HTML    116K 
34: R19         Stockholders' Equity                                HTML     48K 
35: R20         Fair Value Measurement                              HTML     74K 
36: R21         Income Taxes                                        HTML    108K 
37: R22         Commitments and Contingencies                       HTML     44K 
38: R23         Segment Information                                 HTML     57K 
39: R24         Subsequent Event                                    HTML     32K 
40: R25         Summary of Significant Accounting Policies          HTML    145K 
                (Policies)                                                       
41: R26         Revenue (Tables)                                    HTML    103K 
42: R27         Business Combination (Tables)                       HTML     63K 
43: R28         Cash Equivalents and Short-Term Investments         HTML     62K 
                (Tables)                                                         
44: R29         Goodwill and Intangible Assets, net (Tables)        HTML     79K 
45: R30         Inventories (Tables)                                HTML     38K 
46: R31         Balance Sheet Components (Tables)                   HTML     54K 
47: R32         Leases (Tables)                                     HTML     84K 
48: R33         Debt (Tables)                                       HTML     48K 
49: R34         Stock-based Compensation (Tables)                   HTML    106K 
50: R35         Stockholders' Equity (Tables)                       HTML     38K 
51: R36         Fair Value Measurement (Tables)                     HTML     72K 
52: R37         Income Taxes (Tables)                               HTML    104K 
53: R38         Segment Information (Tables)                        HTML     53K 
54: R39         The Company (Details)                               HTML     65K 
55: R40         Summary of Significant Accounting Policies -        HTML     58K 
                Narrative (Details)                                              
56: R41         Revenue -Revenues Disaggregated by Timing of        HTML     57K 
                Transfer of Goods or Services (Details)                          
57: R42         Revenue - Receivables and Contract Liabilities      HTML     40K 
                (Details)                                                        
58: R43         Revenue - Narrative (Details)                       HTML     63K 
59: R44         Revenue - Contract Liabilities from Contracts       HTML     41K 
                (Details)                                                        
60: R45         Revenue - Changes in Our Contract Liabilities from  HTML     35K 
                Contracts (Details)                                              
61: R46         Revenue - Contract Assets from Contracts (Details)  HTML     40K 
62: R47         Business Combination - Narrative (Details)          HTML     52K 
63: R48         Business Combination - Consideration Transferred    HTML     46K 
                (Details)                                                        
64: R49         Business Combination - Fair Value of Assets         HTML     66K 
                Acquired and Liabilities Assumed (Details)                       
65: R50         Business Combination - Intangible Assets Acquired   HTML     47K 
                (Details)                                                        
66: R51         Business Combination - Pro Forma Financial          HTML     34K 
                Information (Details)                                            
67: R52         Cash Equivalents and Short-Term Investments         HTML     54K 
                (Details)                                                        
68: R53         Goodwill and Intangible Assets, net - Narrative     HTML     42K 
                (Details)                                                        
69: R54         Goodwill and Intangible Assets, net - Goodwill      HTML     40K 
                (Details)                                                        
70: R55         Goodwill and Intangible Assets, net - Intangible    HTML     51K 
                Assets and the Remaining Useful Lives (Details)                  
71: R56         Goodwill and Intangible Assets, net - Amortization  HTML     35K 
                Expense (Details)                                                
72: R57         Goodwill and Intangible Assets, net - Expected      HTML     42K 
                Amortization Expense for the Unamortized Acquired                
                Intangible Assets (Details)                                      
73: R58         Inventories (Details)                               HTML     38K 
74: R59         Balance Sheet Components - Schedule of Accrued      HTML     44K 
                Liabilities (Details)                                            
75: R60         Balance Sheet Components - Schedule of Property     HTML     49K 
                and Equipment, Net (Details)                                     
76: R61         Leases - Narrative (Details)                        HTML     87K 
77: R62         Leases - Operating Lease Costs (Details)            HTML     48K 
78: R63         Leases - Maturities of Lease Liabilities (Details)  HTML     85K 
79: R64         Leases - Remaining Lease terms and Discount Rates   HTML     39K 
                (Details)                                                        
80: R65         Leases - Supplemental Cash Flow Information         HTML     42K 
                (Details)                                                        
81: R66         Debt - Carrying Amount of Liability Component       HTML     45K 
                (Details)                                                        
82: R67         Debt - Interest Expense (Details)                   HTML     40K 
83: R68         Debt - Convertible Senior Notes (Details)           HTML     77K 
84: R69         Debt - Notes Payable (Details)                      HTML     68K 
85: R70         Debt - Capped Call Transactions (Details)           HTML     42K 
86: R71         Stock-based Compensation - Stock Option Plan -      HTML    121K 
                Narrative (Details)                                              
87: R72         Stock-based Compensation - Stock Option Plan -      HTML     72K 
                Summary of Stock Option and Restricted Stock                     
                Activity (Details)                                               
88: R73         Stock-based Compensation - Stock Option Plan -      HTML     64K 
                Summary of Restricted Stock Activity (Details)                   
89: R74         Stock-based Compensation - Stock Option Plan -      HTML     49K 
                Fair Value Assumptions (Details)                                 
90: R75         Stock-based Compensation - Stock Option Plan -      HTML     36K 
                Schedule of Stock-based Compensation Expense                     
                (Details)                                                        
91: R76         Stock-based Compensation - Unrecognized             HTML     44K 
                Compensation Cost (Details)                                      
92: R77         Stockholders' Equity (Details)                      HTML     72K 
93: R78         Stockholders? Equity and Stock-Based Compensation   HTML     41K 
                - Common Stock Equivalents Excluded from the                     
                Calculation of Earnings per Share (Details)                      
94: R79         Fair Value Measurement - Schedule of Fair Value of  HTML     77K 
                Financial Instruments (Details)                                  
95: R80         Fair Value Measurement - Summary of Changes in      HTML     44K 
                Fair Value of Financial Instruments (Details)                    
96: R81         Income Taxes -Income Taxes Provision (Benefit)      HTML     57K 
                (Details)                                                        
97: R82         Income Taxes - Effective Tax Rate Reconciliation    HTML     49K 
                (Details)                                                        
98: R83         Income Taxes - Deferred Tax Assets and Liabilities  HTML     68K 
                (Details)                                                        
99: R84         Income Taxes - Narrative (Details)                  HTML     61K 
100: R85         Income Taxes - Unrecognized Tax Benefits (Details)  HTML     36K  
101: R86         Commitments and Contingencies - Additional          HTML     58K  
                Information (Details)                                            
102: R87         Segment Information - Reconciliation of Segment     HTML     43K  
                Revenue to Consolidated Revenue (Details)                        
103: R88         Segment Information - Reconciliation of Segment     HTML     45K  
                Loss from Operations to Consolidated Loss from                   
                Operations (Details)                                             
104: R89         Subsequent Event (Details)                          HTML     49K  
107: XML         IDEA XML File -- Filing Summary                      XML    194K  
105: XML         XBRL Instance -- rvnc-20221231_htm                   XML   3.04M  
106: EXCEL       IDEA Workbook of Financial Reports                  XLSX    224K  
12: EX-101.CAL  XBRL Calculations -- rvnc-20221231_cal               XML    348K 
13: EX-101.DEF  XBRL Definitions -- rvnc-20221231_def                XML   1.01M 
14: EX-101.LAB  XBRL Labels -- rvnc-20221231_lab                     XML   2.40M 
15: EX-101.PRE  XBRL Presentations -- rvnc-20221231_pre              XML   1.51M 
11: EX-101.SCH  XBRL Schema -- rvnc-20221231                         XSD    229K 
108: JSON        XBRL Instance as JSON Data -- MetaLinks              620±   972K  
109: ZIP         XBRL Zipped Folder -- 0001479290-23-000028-xbrl      Zip   1.19M

‘EX-101.SCH’   —   XBRL Schema — rvnc-20221231

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL Document Created with Wdesk from Workiva -->
<!-- Copyright 2023 Workiva -->
<!-- r:a374ae30-633d-442d-87bc-3d1cfba916a3,g:3d6e1605-585e-43ea-898c-6f31a5ac669c -->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rvnc="http://www.revance.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.revance.com/20221231">
<xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
<xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
<xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
<xs:annotation>
<xs:appinfo>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rvnc-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rvnc-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rvnc-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rvnc-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:roleType id="Cover" roleURI="http://www.revance.com/role/Cover">
<link:definition> 0000001 - Document - Cover </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="AuditInformation" roleURI="http://www.revance.com/role/AuditInformation">
<link:definition> 0000002 - Document - Audit Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.revance.com/role/ConsolidatedBalanceSheets">
<link:definition> 0000003 - Statement - Consolidated Balance Sheets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.revance.com/role/ConsolidatedBalanceSheetsParenthetical">
<link:definition> 0000004 - Statement - Consolidated Balance Sheets (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ConsolidatedStatementsofOperationsandComprehensiveLoss" roleURI="http://www.revance.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss">
<link:definition> 0000005 - Statement - Consolidated Statements of Operations and Comprehensive Loss </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.revance.com/role/ConsolidatedStatementsofStockholdersEquity">
<link:definition> 0000006 - Statement - Consolidated Statements of Stockholders' Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.revance.com/role/ConsolidatedStatementsofCashFlows">
<link:definition> 0000007 - Statement - Consolidated Statements of Cash Flows </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="TheCompany" roleURI="http://www.revance.com/role/TheCompany">
<link:definition> 0000008 - Disclosure - The Company </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.revance.com/role/SummaryofSignificantAccountingPolicies">
<link:definition> 0000009 - Disclosure - Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Revenue" roleURI="http://www.revance.com/role/Revenue">
<link:definition> 0000010 - Disclosure - Revenue </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BusinessCombination" roleURI="http://www.revance.com/role/BusinessCombination">
<link:definition> 0000011 - Disclosure - Business Combination </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CashEquivalentsandShortTermInvestments" roleURI="http://www.revance.com/role/CashEquivalentsandShortTermInvestments">
<link:definition> 0000012 - Disclosure - Cash Equivalents and Short-Term Investments </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="GoodwillandIntangibleAssetsnet" roleURI="http://www.revance.com/role/GoodwillandIntangibleAssetsnet">
<link:definition> 0000013 - Disclosure - Goodwill and Intangible Assets, net </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Inventories" roleURI="http://www.revance.com/role/Inventories">
<link:definition> 0000014 - Disclosure - Inventories </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BalanceSheetComponents" roleURI="http://www.revance.com/role/BalanceSheetComponents">
<link:definition> 0000015 - Disclosure - Balance Sheet Components </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Leases" roleURI="http://www.revance.com/role/Leases">
<link:definition> 0000016 - Disclosure - Leases </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Debt" roleURI="http://www.revance.com/role/Debt">
<link:definition> 0000017 - Disclosure - Debt </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockbasedCompensation" roleURI="http://www.revance.com/role/StockbasedCompensation">
<link:definition> 0000018 - Disclosure - Stock-based Compensation </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockholdersEquity" roleURI="http://www.revance.com/role/StockholdersEquity">
<link:definition> 0000019 - Disclosure - Stockholders' Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="FairValueMeasurement" roleURI="http://www.revance.com/role/FairValueMeasurement">
<link:definition> 0000020 - Disclosure - Fair Value Measurement </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxes" roleURI="http://www.revance.com/role/IncomeTaxes">
<link:definition> 0000021 - Disclosure - Income Taxes </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsandContingencies" roleURI="http://www.revance.com/role/CommitmentsandContingencies">
<link:definition> 0000022 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SegmentInformation" roleURI="http://www.revance.com/role/SegmentInformation">
<link:definition> 0000023 - Disclosure - Segment Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SubsequentEvent" roleURI="http://www.revance.com/role/SubsequentEvent">
<link:definition> 0000024 - Disclosure - Subsequent Event </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.revance.com/role/SummaryofSignificantAccountingPoliciesPolicies">
<link:definition> 0000025 - Disclosure - Summary of Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueTables" roleURI="http://www.revance.com/role/RevenueTables">
<link:definition> 0000026 - Disclosure - Revenue (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BusinessCombinationTables" roleURI="http://www.revance.com/role/BusinessCombinationTables">
<link:definition> 0000027 - Disclosure - Business Combination (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CashEquivalentsandShortTermInvestmentsTables" roleURI="http://www.revance.com/role/CashEquivalentsandShortTermInvestmentsTables">
<link:definition> 0000028 - Disclosure - Cash Equivalents and Short-Term Investments (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="GoodwillandIntangibleAssetsnetTables" roleURI="http://www.revance.com/role/GoodwillandIntangibleAssetsnetTables">
<link:definition> 0000029 - Disclosure - Goodwill and Intangible Assets, net (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="InventoriesTables" roleURI="http://www.revance.com/role/InventoriesTables">
<link:definition> 0000030 - Disclosure - Inventories (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BalanceSheetComponentsTables" roleURI="http://www.revance.com/role/BalanceSheetComponentsTables">
<link:definition> 0000031 - Disclosure - Balance Sheet Components (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LeasesTables" roleURI="http://www.revance.com/role/LeasesTables">
<link:definition> 0000032 - Disclosure - Leases (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DebtTables" roleURI="http://www.revance.com/role/DebtTables">
<link:definition> 0000033 - Disclosure - Debt (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockbasedCompensationTables" roleURI="http://www.revance.com/role/StockbasedCompensationTables">
<link:definition> 0000034 - Disclosure - Stock-based Compensation (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockholdersEquityTables" roleURI="http://www.revance.com/role/StockholdersEquityTables">
<link:definition> 0000035 - Disclosure - Stockholders' Equity (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="FairValueMeasurementTables" roleURI="http://www.revance.com/role/FairValueMeasurementTables">
<link:definition> 0000036 - Disclosure - Fair Value Measurement (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesTables" roleURI="http://www.revance.com/role/IncomeTaxesTables">
<link:definition> 0000037 - Disclosure - Income Taxes (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SegmentInformationTables" roleURI="http://www.revance.com/role/SegmentInformationTables">
<link:definition> 0000038 - Disclosure - Segment Information (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="TheCompanyDetails" roleURI="http://www.revance.com/role/TheCompanyDetails">
<link:definition> 0000039 - Disclosure - The Company (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.revance.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
<link:definition> 0000040 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueRevenuesDisaggregatedbyTimingofTransferofGoodsorServicesDetails" roleURI="http://www.revance.com/role/RevenueRevenuesDisaggregatedbyTimingofTransferofGoodsorServicesDetails">
<link:definition> 0000041 - Disclosure - Revenue -Revenues Disaggregated by Timing of Transfer of Goods or Services (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueReceivablesandContractLiabilitiesDetails" roleURI="http://www.revance.com/role/RevenueReceivablesandContractLiabilitiesDetails">
<link:definition> 0000042 - Disclosure - Revenue - Receivables and Contract Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueNarrativeDetails" roleURI="http://www.revance.com/role/RevenueNarrativeDetails">
<link:definition> 0000043 - Disclosure - Revenue - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueContractLiabilitiesfromContractsDetails" roleURI="http://www.revance.com/role/RevenueContractLiabilitiesfromContractsDetails">
<link:definition> 0000044 - Disclosure - Revenue - Contract Liabilities from Contracts (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueChangesinOurContractLiabilitiesfromContractsDetails" roleURI="http://www.revance.com/role/RevenueChangesinOurContractLiabilitiesfromContractsDetails">
<link:definition> 0000045 - Disclosure - Revenue - Changes in Our Contract Liabilities from Contracts (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueContractAssetsfromContractsDetails" roleURI="http://www.revance.com/role/RevenueContractAssetsfromContractsDetails">
<link:definition> 0000046 - Disclosure - Revenue - Contract Assets from Contracts (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BusinessCombinationNarrativeDetails" roleURI="http://www.revance.com/role/BusinessCombinationNarrativeDetails">
<link:definition> 0000047 - Disclosure - Business Combination - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BusinessCombinationConsiderationTransferredDetails" roleURI="http://www.revance.com/role/BusinessCombinationConsiderationTransferredDetails">
<link:definition> 0000048 - Disclosure - Business Combination - Consideration Transferred (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BusinessCombinationFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.revance.com/role/BusinessCombinationFairValueofAssetsAcquiredandLiabilitiesAssumedDetails">
<link:definition> 0000049 - Disclosure - Business Combination - Fair Value of Assets Acquired and Liabilities Assumed (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BusinessCombinationIntangibleAssetsAcquiredDetails" roleURI="http://www.revance.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails">
<link:definition> 0000050 - Disclosure - Business Combination - Intangible Assets Acquired (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BusinessCombinationProFormaFinancialInformationDetails" roleURI="http://www.revance.com/role/BusinessCombinationProFormaFinancialInformationDetails">
<link:definition> 0000051 - Disclosure - Business Combination - Pro Forma Financial Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CashEquivalentsandShortTermInvestmentsDetails" roleURI="http://www.revance.com/role/CashEquivalentsandShortTermInvestmentsDetails">
<link:definition> 0000052 - Disclosure - Cash Equivalents and Short-Term Investments (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="GoodwillandIntangibleAssetsnetNarrativeDetails" roleURI="http://www.revance.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails">
<link:definition> 0000053 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="GoodwillandIntangibleAssetsnetGoodwillDetails" roleURI="http://www.revance.com/role/GoodwillandIntangibleAssetsnetGoodwillDetails">
<link:definition> 0000054 - Disclosure - Goodwill and Intangible Assets, net - Goodwill (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="GoodwillandIntangibleAssetsnetIntangibleAssetsandtheRemainingUsefulLivesDetails" roleURI="http://www.revance.com/role/GoodwillandIntangibleAssetsnetIntangibleAssetsandtheRemainingUsefulLivesDetails">
<link:definition> 0000055 - Disclosure - Goodwill and Intangible Assets, net - Intangible Assets and the Remaining Useful Lives (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="GoodwillandIntangibleAssetsnetIntangibleAssetsandtheRemainingUsefulLivesDetails_1" roleURI="http://www.revance.com/role/GoodwillandIntangibleAssetsnetIntangibleAssetsandtheRemainingUsefulLivesDetails_1">
<link:definition> 0000055 - Disclosure - Goodwill and Intangible Assets, net - Intangible Assets and the Remaining Useful Lives (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="GoodwillandIntangibleAssetsnetAmortizationExpenseDetails" roleURI="http://www.revance.com/role/GoodwillandIntangibleAssetsnetAmortizationExpenseDetails">
<link:definition> 0000056 - Disclosure - Goodwill and Intangible Assets, net - Amortization Expense (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="GoodwillandIntangibleAssetsnetExpectedAmortizationExpensefortheUnamortizedAcquiredIntangibleAssetsDetails" roleURI="http://www.revance.com/role/GoodwillandIntangibleAssetsnetExpectedAmortizationExpensefortheUnamortizedAcquiredIntangibleAssetsDetails">
<link:definition> 0000057 - Disclosure - Goodwill and Intangible Assets, net - Expected Amortization Expense for the Unamortized Acquired Intangible Assets (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="InventoriesDetails" roleURI="http://www.revance.com/role/InventoriesDetails">
<link:definition> 0000058 - Disclosure - Inventories (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BalanceSheetComponentsScheduleofAccruedLiabilitiesDetails" roleURI="http://www.revance.com/role/BalanceSheetComponentsScheduleofAccruedLiabilitiesDetails">
<link:definition> 0000059 - Disclosure - Balance Sheet Components - Schedule of Accrued Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" roleURI="http://www.revance.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails">
<link:definition> 0000060 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LeasesNarrativeDetails" roleURI="http://www.revance.com/role/LeasesNarrativeDetails">
<link:definition> 0000061 - Disclosure - Leases - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LeasesOperatingLeaseCostsDetails" roleURI="http://www.revance.com/role/LeasesOperatingLeaseCostsDetails">
<link:definition> 0000062 - Disclosure - Leases - Operating Lease Costs (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails" roleURI="http://www.revance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails">
<link:definition> 0000063 - Disclosure - Leases - Maturities of Lease Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://www.revance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1">
<link:definition> 0000063 - Disclosure - Leases - Maturities of Lease Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails_2" roleURI="http://www.revance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2">
<link:definition> 0000063 - Disclosure - Leases - Maturities of Lease Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LeasesRemainingLeasetermsandDiscountRatesDetails" roleURI="http://www.revance.com/role/LeasesRemainingLeasetermsandDiscountRatesDetails">
<link:definition> 0000064 - Disclosure - Leases - Remaining Lease terms and Discount Rates (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.revance.com/role/LeasesSupplementalCashFlowInformationDetails">
<link:definition> 0000065 - Disclosure - Leases - Supplemental Cash Flow Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DebtCarryingAmountofLiabilityComponentDetails" roleURI="http://www.revance.com/role/DebtCarryingAmountofLiabilityComponentDetails">
<link:definition> 0000066 - Disclosure - Debt - Carrying Amount of Liability Component (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DebtInterestExpenseDetails" roleURI="http://www.revance.com/role/DebtInterestExpenseDetails">
<link:definition> 0000067 - Disclosure - Debt - Interest Expense (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DebtConvertibleSeniorNotesDetails" roleURI="http://www.revance.com/role/DebtConvertibleSeniorNotesDetails">
<link:definition> 0000068 - Disclosure - Debt - Convertible Senior Notes (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DebtNotesPayableDetails" roleURI="http://www.revance.com/role/DebtNotesPayableDetails">
<link:definition> 0000069 - Disclosure - Debt - Notes Payable (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DebtCappedCallTransactionsDetails" roleURI="http://www.revance.com/role/DebtCappedCallTransactionsDetails">
<link:definition> 0000070 - Disclosure - Debt - Capped Call Transactions (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockbasedCompensationStockOptionPlanNarrativeDetails" roleURI="http://www.revance.com/role/StockbasedCompensationStockOptionPlanNarrativeDetails">
<link:definition> 0000071 - Disclosure - Stock-based Compensation - Stock Option Plan - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockbasedCompensationStockOptionPlanSummaryofStockOptionandRestrictedStockActivityDetails" roleURI="http://www.revance.com/role/StockbasedCompensationStockOptionPlanSummaryofStockOptionandRestrictedStockActivityDetails">
<link:definition> 0000072 - Disclosure - Stock-based Compensation - Stock Option Plan - Summary of Stock Option and Restricted Stock Activity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockbasedCompensationStockOptionPlanSummaryofRestrictedStockActivityDetails" roleURI="http://www.revance.com/role/StockbasedCompensationStockOptionPlanSummaryofRestrictedStockActivityDetails">
<link:definition> 0000073 - Disclosure - Stock-based Compensation - Stock Option Plan - Summary of Restricted Stock Activity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockbasedCompensationStockOptionPlanFairValueAssumptionsDetails" roleURI="http://www.revance.com/role/StockbasedCompensationStockOptionPlanFairValueAssumptionsDetails">
<link:definition> 0000074 - Disclosure - Stock-based Compensation - Stock Option Plan - Fair Value Assumptions (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockbasedCompensationStockOptionPlanScheduleofStockbasedCompensationExpenseDetails" roleURI="http://www.revance.com/role/StockbasedCompensationStockOptionPlanScheduleofStockbasedCompensationExpenseDetails">
<link:definition> 0000075 - Disclosure - Stock-based Compensation - Stock Option Plan - Schedule of Stock-based Compensation Expense (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockbasedCompensationUnrecognizedCompensationCostDetails" roleURI="http://www.revance.com/role/StockbasedCompensationUnrecognizedCompensationCostDetails">
<link:definition> 0000076 - Disclosure - Stock-based Compensation - Unrecognized Compensation Cost (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockholdersEquityDetails" roleURI="http://www.revance.com/role/StockholdersEquityDetails">
<link:definition> 0000077 - Disclosure - Stockholders' Equity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockholdersEquityandStockBasedCompensationCommonStockEquivalentsExcludedfromtheCalculationofEarningsperShareDetails" roleURI="http://www.revance.com/role/StockholdersEquityandStockBasedCompensationCommonStockEquivalentsExcludedfromtheCalculationofEarningsperShareDetails">
<link:definition> 0000078 - Disclosure - Stockholders’ Equity and Stock-Based Compensation - Common Stock Equivalents Excluded from the Calculation of Earnings per Share (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="FairValueMeasurementScheduleofFairValueofFinancialInstrumentsDetails" roleURI="http://www.revance.com/role/FairValueMeasurementScheduleofFairValueofFinancialInstrumentsDetails">
<link:definition> 0000079 - Disclosure - Fair Value Measurement - Schedule of Fair Value of Financial Instruments (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="FairValueMeasurementSummaryofChangesinFairValueofFinancialInstrumentsDetails" roleURI="http://www.revance.com/role/FairValueMeasurementSummaryofChangesinFairValueofFinancialInstrumentsDetails">
<link:definition> 0000080 - Disclosure - Fair Value Measurement - Summary of Changes in Fair Value of Financial Instruments (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesIncomeTaxesProvisionBenefitDetails" roleURI="http://www.revance.com/role/IncomeTaxesIncomeTaxesProvisionBenefitDetails">
<link:definition> 0000081 - Disclosure - Income Taxes -Income Taxes Provision (Benefit) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesEffectiveTaxRateReconciliationDetails" roleURI="http://www.revance.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails">
<link:definition> 0000082 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.revance.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
<link:definition> 0000083 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.revance.com/role/IncomeTaxesNarrativeDetails">
<link:definition> 0000084 - Disclosure - Income Taxes - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesUnrecognizedTaxBenefitsDetails" roleURI="http://www.revance.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails">
<link:definition> 0000085 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsandContingenciesAdditionalInformationDetails" roleURI="http://www.revance.com/role/CommitmentsandContingenciesAdditionalInformationDetails">
<link:definition> 0000086 - Disclosure - Commitments and Contingencies - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SegmentInformationReconciliationofSegmentRevenuetoConsolidatedRevenueDetails" roleURI="http://www.revance.com/role/SegmentInformationReconciliationofSegmentRevenuetoConsolidatedRevenueDetails">
<link:definition> 0000087 - Disclosure - Segment Information - Reconciliation of Segment Revenue to Consolidated Revenue (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SegmentInformationReconciliationofSegmentLossfromOperationstoConsolidatedLossfromOperationsDetails" roleURI="http://www.revance.com/role/SegmentInformationReconciliationofSegmentLossfromOperationstoConsolidatedLossfromOperationsDetails">
<link:definition> 0000088 - Disclosure - Segment Information - Reconciliation of Segment Loss from Operations to Consolidated Loss from Operations (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SubsequentEventDetails" roleURI="http://www.revance.com/role/SubsequentEventDetails">
<link:definition> 0000089 - Disclosure - Subsequent Event (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
</xs:appinfo>
</xs:annotation>
<xs:element id="rvnc_HintMDMember" abstract="true" name="HintMDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_DebtConversionTermsTwoMember" abstract="true" name="DebtConversionTermsTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_LeaseLiabilityPaymentsDueAfterYearFive" abstract="false" name="LeaseLiabilityPaymentsDueAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_ViatrisMember" abstract="true" name="ViatrisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_LabEquipmentAndFurnitureAndFixturesAndVehiclesMember" abstract="true" name="LabEquipmentAndFurnitureAndFixturesAndVehiclesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisedAggregateIntrinsicValue" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisedAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_DebtInstrumentDebtDefaultAdditionalInterestRateToFixed" abstract="false" name="DebtInstrumentDebtDefaultAdditionalInterestRateToFixed" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
<xs:element id="rvnc_MonteCarloSimulationModelMember" abstract="true" name="MonteCarloSimulationModelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_LesseeSupplementalCashFlowInformationTableTextBlock" abstract="false" name="LesseeSupplementalCashFlowInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
<xs:element id="rvnc_DebtConversionTermsOneMember" abstract="true" name="DebtConversionTermsOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_FinanceLeasePrepaidExpenseNoncurrent" abstract="false" name="FinanceLeasePrepaidExpenseNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_StockIssuanceSalesAgreementAuthorizedOfferingPriceMaximum" abstract="false" name="StockIssuanceSalesAgreementAuthorizedOfferingPriceMaximum" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_PurchaseObligationEliminatedYearThree" abstract="false" name="PurchaseObligationEliminatedYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_StockIssuedDuringPeriodSharesRestrictedStockAwardCancelled" abstract="false" name="StockIssuedDuringPeriodSharesRestrictedStockAwardCancelled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="rvnc_InternallyDevelopedSoftwareCapitalizedFromStockBasedCompensation" abstract="false" name="InternallyDevelopedSoftwareCapitalizedFromStockBasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_CollaborativeAgreementMinimumExpendituresRelatedToCommercializationYearOne" abstract="false" name="CollaborativeAgreementMinimumExpendituresRelatedToCommercializationYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="rvnc_CappedCallsPremiumPercentageOverSalePrice" abstract="false" name="CappedCallsPremiumPercentageOverSalePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
<xs:element id="rvnc_A2014ESPPMember" abstract="true" name="A2014ESPPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_AccrualsClinicalTrialsCurrent" abstract="false" name="AccrualsClinicalTrialsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_NumberOfCoDefendants" abstract="false" name="NumberOfCoDefendants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="rvnc_UnvestedRestrictedStockAwardsMember" abstract="true" name="UnvestedRestrictedStockAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_ProceedsFromIssuanceOfFollowOnOfferingNetOfDiscountAndCommissions" abstract="false" name="ProceedsFromIssuanceOfFollowOnOfferingNetOfDiscountAndCommissions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_BusinessCombinationConsiderationTransferredEquityInterestIssuedAndIssuableEntitySharesIssuedPerAcquireeShare" abstract="false" name="BusinessCombinationConsiderationTransferredEquityInterestIssuedAndIssuableEntitySharesIssuedPerAcquireeShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="rvnc_A2017EquityIncentivePlanHintMDPlanMember" abstract="true" name="A2017EquityIncentivePlanHintMDPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_LeaseLiabilityToBePaymentDue" abstract="false" name="LeaseLiabilityToBePaymentDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_DerivativeLiabilitySettlementMember" abstract="true" name="DerivativeLiabilitySettlementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_LossContingencyNumberOfAdditionalPatentInfringementClaims" abstract="false" name="LossContingencyNumberOfAdditionalPatentInfringementClaims" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="rvnc_DebtInstrumentDebtCovenantMinimumCashBalanceMaintained" abstract="false" name="DebtInstrumentDebtCovenantMinimumCashBalanceMaintained" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" abstract="true" name="RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="rvnc_BotulinumToxinResearchAssociatesInc.Member" abstract="true" name="BotulinumToxinResearchAssociatesInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_CorporateBondMember" abstract="true" name="CorporateBondMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_DebtInstrumentCovenantAchievementTrailingTwelveMonthsRevenue" abstract="false" name="DebtInstrumentCovenantAchievementTrailingTwelveMonthsRevenue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_CollaborativeAgreementNumberOfExtensionPeriods" abstract="false" name="CollaborativeAgreementNumberOfExtensionPeriods" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="rvnc_LyophilizationServicesOfNewEnglandIncMember" abstract="true" name="LyophilizationServicesOfNewEnglandIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_TwoThousandAndFourteenEmployeeStockPurchasePlanMember" abstract="true" name="TwoThousandAndFourteenEmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_PrepaymentsForAFinanceLease" abstract="false" name="PrepaymentsForAFinanceLease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_CollaborativeAgreementContractualPeriod" abstract="false" name="CollaborativeAgreementContractualPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="rvnc_NumberOfThirdPartyDistributorsForEachProduct" abstract="false" name="NumberOfThirdPartyDistributorsForEachProduct" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="rvnc_NotePurchaseAgreementMember" abstract="true" name="NotePurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_CollaborativeAgreementMinimumExpendituresRelatedToCommercializationYearTwo" abstract="false" name="CollaborativeAgreementMinimumExpendituresRelatedToCommercializationYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_IncreaseDecreaseinOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseinOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_SharePriceWeightedAverage" abstract="false" name="SharePriceWeightedAverage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
<xs:element id="rvnc_StockIssuedDuringPeriodSharesRestrictedStockAwardNetofSharesRepurchased" abstract="false" name="StockIssuedDuringPeriodSharesRestrictedStockAwardNetofSharesRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="rvnc_CappedCallsNumberOfSharesSubjectToAntiDilutionAdjustments" abstract="false" name="CappedCallsNumberOfSharesSubjectToAntiDilutionAdjustments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="rvnc_FollowOnOfferingMember" abstract="true" name="FollowOnOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_OperatingLeaseAbstract" abstract="true" name="OperatingLeaseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="rvnc_AtTheMarketOffering2022PlanMember" abstract="true" name="AtTheMarketOffering2022PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_StockIssuedDuringPeriodShareNewIssuesFollowOnOfferingNetOfUnderwritingDiscountsCommissionsAndOfferingCost" abstract="false" name="StockIssuedDuringPeriodShareNewIssuesFollowOnOfferingNetOfUnderwritingDiscountsCommissionsAndOfferingCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="rvnc_SharebasedCompensationArrangementBySharebasedPaymentAwardRemainingVestingRightsPercentage" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardRemainingVestingRightsPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
<xs:element id="rvnc_ShanghaiFosunPharmaceuticalIndustrialDevelopmentCo.Ltd.Member" abstract="true" name="ShanghaiFosunPharmaceuticalIndustrialDevelopmentCo.Ltd.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_RoyaltiesMaximumAnnualSalesOfRoyaltiesWaived" abstract="false" name="RoyaltiesMaximumAnnualSalesOfRoyaltiesWaived" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_CappedCallsPriceCap" abstract="false" name="CappedCallsPriceCap" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
<xs:element id="rvnc_DevelopmentServicesMember" abstract="true" name="DevelopmentServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_GoodwillImpairmentMeasurementInput" abstract="false" name="GoodwillImpairmentMeasurementInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
<xs:element id="rvnc_BusinessAcquisitionEquityInterestIssuedNumberOfShares" abstract="false" name="BusinessAcquisitionEquityInterestIssuedNumberOfShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="rvnc_LeaseLiabilityToBePaymentDueYearFive" abstract="false" name="LeaseLiabilityToBePaymentDueYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_IncreaseDecreaseinOperatingLeaseRightofUseAssets" abstract="false" name="IncreaseDecreaseinOperatingLeaseRightofUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_ManufacturingEquipmentMember" abstract="true" name="ManufacturingEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_AmortizationMember" abstract="true" name="AmortizationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_FinanceLeaseAbstract" abstract="true" name="FinanceLeaseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="rvnc_ProductSegmentMember" abstract="true" name="ProductSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_LeaseLiabilityToBePaymentDueYearFour" abstract="false" name="LeaseLiabilityToBePaymentDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_AttheMarketOfferingMember" abstract="true" name="AttheMarketOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_ClinicalTrialAccrualsPolicyPolicyTextBlock" abstract="false" name="ClinicalTrialAccrualsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
<xs:element id="rvnc_AccruedInventoryCurrent" abstract="false" name="AccruedInventoryCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_NashvilleLeaseExpansionPremisesMember" abstract="true" name="NashvilleLeaseExpansionPremisesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_OrphanDrugCreditCarryforwardMember" abstract="true" name="OrphanDrugCreditCarryforwardMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_DebtInstrumentDebtCovenantMinimumNetSalesRequirement" abstract="false" name="DebtInstrumentDebtCovenantMinimumNetSalesRequirement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_RHACollectionMember" abstract="true" name="RHACollectionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_TwentyTwentySevenNotesMember" abstract="true" name="TwentyTwentySevenNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_RevenueRecognitionMilestoneMethodMaximumRevenue" abstract="false" name="RevenueRecognitionMilestoneMethodMaximumRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_StockIssuedDuringPeriodValueNewIssuesFollowOnOfferingNetOfUnderwritingDiscountsCommissionsAndOfferingCost" abstract="false" name="StockIssuedDuringPeriodValueNewIssuesFollowOnOfferingNetOfUnderwritingDiscountsCommissionsAndOfferingCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisDerecognitionOfDerivativeLiability" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisDerecognitionOfDerivativeLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_DeferredTaxAssetsInterestLimiation" abstract="false" name="DeferredTaxAssetsInterestLimiation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_OperatingLeasesRemainingLeaseTermsAndDiscountRatesAbstract" abstract="true" name="OperatingLeasesRemainingLeaseTermsAndDiscountRatesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="rvnc_FinanceLeaseVariableCost" abstract="false" name="FinanceLeaseVariableCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_TotalFinanceLeaseCosts" abstract="false" name="TotalFinanceLeaseCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_DeferredTaxAssetOperatingLeaseLiabilities" abstract="false" name="DeferredTaxAssetOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesAvailableForPurchase" abstract="false" name="BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesAvailableForPurchase" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="rvnc_DebtInstrumentConvertibleTermsOfConversionDomain" abstract="true" name="DebtInstrumentConvertibleTermsOfConversionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_DebtInstrumentConvertibleThresholdPercentageOfStockTradingPrice" abstract="false" name="DebtInstrumentConvertibleThresholdPercentageOfStockTradingPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
<xs:element id="rvnc_NumberofEquityCompensationPlans" abstract="false" name="NumberofEquityCompensationPlans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="rvnc_NonCashIncomeTaxExpenseBenefit" abstract="false" name="NonCashIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_DAXXIFYMember" abstract="true" name="DAXXIFYMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_TwoThousandAndFourteenInducementPlanMember" abstract="true" name="TwoThousandAndFourteenInducementPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_LesseeOperatingLeaseNumberOfRenewalOptions" abstract="false" name="LesseeOperatingLeaseNumberOfRenewalOptions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="rvnc_PurchaseObligationTermOfWrittenNotice" abstract="false" name="PurchaseObligationTermOfWrittenNotice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="rvnc_TwoThousandAndFourteenEquityIncentivePlanMember" abstract="true" name="TwoThousandAndFourteenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_LesseeOperatingLeaseLeaseNotYetCommencedAmount" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_LeaseLiabilityToBePaymentDueYearThree" abstract="false" name="LeaseLiabilityToBePaymentDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_TeoxaneAgreementMember" abstract="true" name="TeoxaneAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_WorkingCapitalSurplus" abstract="false" name="WorkingCapitalSurplus" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_NumberOfDebilitatingConditions" abstract="false" name="NumberOfDebilitatingConditions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="rvnc_EffectiveIncomeTaxRateReconciliationNonDeductibleExecutiveCompensation" abstract="false" name="EffectiveIncomeTaxRateReconciliationNonDeductibleExecutiveCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_CashFlowLesseeAbstract" abstract="true" name="CashFlowLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="rvnc_PurchaseObligationEliminatedYearOne" abstract="false" name="PurchaseObligationEliminatedYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_ContingentLicensingRoyaltyRevenue" abstract="false" name="ContingentLicensingRoyaltyRevenue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_CollaborativeAgreementExtendedContractualPeriod" abstract="false" name="CollaborativeAgreementExtendedContractualPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="rvnc_ContractWithCustomerLiabilityBillingsAndAdjustmentsNet" abstract="false" name="ContractWithCustomerLiabilityBillingsAndAdjustmentsNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_ServiceSegmentMember" abstract="true" name="ServiceSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_RestrictedStockAndRestrictedStockUnitsMember" abstract="true" name="RestrictedStockAndRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_DebtInstrumentConvertibleTermsOfConversionAxis" abstract="true" name="DebtInstrumentConvertibleTermsOfConversionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
<xs:element id="rvnc_OtherStatesMember" abstract="true" name="OtherStatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_FinanceLeasesRemainingLeaseTermsAndDiscountRatesAbstract" abstract="true" name="FinanceLeasesRemainingLeaseTermsAndDiscountRatesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="rvnc_ContractWithCustomerAssetAndLiabilityRollForward" abstract="true" name="ContractWithCustomerAssetAndLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="rvnc_RestrictedCashMinimumBalance" abstract="false" name="RestrictedCashMinimumBalance" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_AccruedMilestoneObligations" abstract="false" name="AccruedMilestoneObligations" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_PurchaseObligationEliminatedYearTwo" abstract="false" name="PurchaseObligationEliminatedYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_ResearchAndManufacturingEquipmentMember" abstract="true" name="ResearchAndManufacturingEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfSharesRepurchased" abstract="false" name="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfSharesRepurchased" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_RoyaltiesMaximumAnnualSalesOfRoyaltiesWaivedMaturityPeriod" abstract="false" name="RoyaltiesMaximumAnnualSalesOfRoyaltiesWaivedMaturityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="rvnc_SaleofStockIssuanceCostsCommissionPercentageMaximum" abstract="false" name="SaleofStockIssuanceCostsCommissionPercentageMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
<xs:element id="rvnc_PerformanceStockAwardsAndPerformanceStockUnitsMember" abstract="true" name="PerformanceStockAwardsAndPerformanceStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_TotalOperatingLeaseCosts" abstract="false" name="TotalOperatingLeaseCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_BusinessCombinationConsiderationTransferredEquityInterestsIssuedPreCombinationService" abstract="false" name="BusinessCombinationConsiderationTransferredEquityInterestsIssuedPreCombinationService" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_CollaborationRevenueMember" abstract="true" name="CollaborationRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_SharebasedPaymentArrangementTrancheFiveMember" abstract="true" name="SharebasedPaymentArrangementTrancheFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesInEscrow" abstract="false" name="BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesInEscrow" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="rvnc_OperatingAndFinanceLeaseLiabilitiesPaymentsDueAbstract" abstract="true" name="OperatingAndFinanceLeaseLiabilitiesPaymentsDueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="rvnc_IndemnificationLiabilityRecordedduringPeriod" abstract="false" name="IndemnificationLiabilityRecordedduringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_LeaseLiabilityUndiscountedExcessAmount" abstract="false" name="LeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_LeaseLiabilityToBePaymentDueYearTwo" abstract="false" name="LeaseLiabilityToBePaymentDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_DebtInstrumentPrepaidFeePercent" abstract="false" name="DebtInstrumentPrepaidFeePercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
<xs:element id="rvnc_ResearchAndDevelopmentAccrual" abstract="false" name="ResearchAndDevelopmentAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_LeaseLiabilityToBePaymentDueYearOne" abstract="false" name="LeaseLiabilityToBePaymentDueYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_SellingGeneralAndAdministrativeAccrued" abstract="false" name="SellingGeneralAndAdministrativeAccrued" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="rvnc_AtTheMarketOffering2020PlanMember" abstract="true" name="AtTheMarketOffering2020PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="rvnc_AdjustmentToAdditionalPaidInCapitalCappedCallTransactions" abstract="false" name="AdjustmentToAdditionalPaidInCapitalCappedCallTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>

6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/05/24  Revance Therapeutics, Inc.        424B5                  2:551K                                   Donnelley … Solutions/FA
 3/04/24  Revance Therapeutics, Inc.        424B5                  1:535K                                   Donnelley … Solutions/FA
 2/28/24  Revance Therapeutics, Inc.        10-K       12/31/23  110:12M
11/14/23  Revance Therapeutics, Inc.        S-3ASR     11/14/23    7:846K                                   Donnelley … Solutions/FA
 3/23/23  Revance Therapeutics, Inc.        DEF 14A               12:12M
 2/28/23  Revance Therapeutics, Inc.        S-8         2/28/23    5:192K

29 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/08/22  Revance Therapeutics, Inc.        10-Q        9/30/22   78:9.1M
 5/10/22  Revance Therapeutics, Inc.        10-Q        3/31/22   82:9M                                     Donnelley … Solutions/FA
 2/28/22  Revance Therapeutics, Inc.        S-8         2/28/22    5:197K
 2/28/22  Revance Therapeutics, Inc.        10-K       12/31/21  106:12M
12/22/21  Revance Therapeutics, Inc.        8-K:5,9    12/17/21   11:385K
11/09/21  Revance Therapeutics, Inc.        10-Q        9/30/21   81:8.4M
 8/05/21  Revance Therapeutics, Inc.        10-Q        6/30/21   79:8.5M
 5/10/21  Revance Therapeutics, Inc.        10-Q        3/31/21   76:6.7M
 5/07/21  Revance Therapeutics, Inc.        8-K:5,9     5/05/21   13:192K
 2/25/21  Revance Therapeutics, Inc.        10-K       12/31/20  109:12M
11/20/20  Revance Therapeutics, Inc.        8-K:1,2,9  11/17/20   13:854K
11/09/20  Revance Therapeutics, Inc.        10-Q        9/30/20   83:8.3M
 8/06/20  Revance Therapeutics, Inc.        10-Q        6/30/20   64:7.2M
 7/24/20  Revance Therapeutics, Inc.        S-8         7/24/20    4:169K                                   Donnelley … Solutions/FA
 6/10/20  Revance Therapeutics, Inc.        S-4                   94:11M                                    Donnelley … Solutions/FA
 2/26/20  Revance Therapeutics, Inc.        10-K       12/31/19   85:11M
 2/14/20  Revance Therapeutics, Inc.        8-K:1,2,3,8 2/11/20   14:1.4M                                   Donnelley … Solutions/FA
11/04/19  Revance Therapeutics, Inc.        10-Q        9/30/19   60:5.7M
 2/28/19  Revance Therapeutics, Inc.        10-K       12/31/18   86:11M
 5/11/18  Revance Therapeutics, Inc.        8-K:1,5,9   5/10/18    2:261K
 5/09/18  Revance Therapeutics, Inc.        10-Q        3/31/18   54:4.5M
 5/09/17  Revance Therapeutics, Inc.        10-Q        3/31/17   63:4.4M
 3/04/16  Revance Therapeutics, Inc.        10-K       12/31/15   99:11M
11/10/15  Revance Therapeutics, Inc.        10-Q        9/30/15   66:5.6M
 3/04/14  Revance Therapeutics, Inc.        8-K:1,9     2/26/14    2:52K                                    Donnelley … Solutions/FA
 2/11/14  Revance Therapeutics, Inc.        8-K:5,9     2/11/14    2:49K                                    Donnelley … Solutions/FA
 2/03/14  Revance Therapeutics, Inc.        S-1/A                  5:4.8M                                   Donnelley … Solutions/FA
 1/27/14  Revance Therapeutics, Inc.        S-1/A¶                22:5.2M                                   Donnelley … Solutions/FA
12/31/13  Revance Therapeutics, Inc.        S-1¶                  30:11M                                    Donnelley … Solutions/FA
↑Top
Filing Submission 0001479290-23-000028   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Mon., May 13, 6:38:24.4am ET